• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Risk factors determine need for CTA for PE

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 32 No 7
Volume 32
Issue 7

Risk factor assessments can rule out the need for CT angiography for pulmonary embolism, according to a new study published in Radiology.

Risk factor assessments can rule out the need for CT angiography for pulmonary embolism, according to a new study published in Radiology.

CT angiograms were negative for pulmonary embolism (PE) in 90.2% of 2003 patients, according to researchers at the University of California, Irvine. Among the 197 patients positive for PE, 97.5% had one or more risk factors. The risk factors were age, gender, cancer, history of immbolization, excess estrogen rate, a history of venous thromboembolism, and disorders that cause blood to clot easily.

All risk factors except gender were considered statistically significant. Age of 65 years or older and immobilization were the most common risk factors in positive PE patients. Risk factor assessment had a sensitivity of 97.5% and a negative predictive value of 99% in all patients.

Of the patients negative for PE, 28.8% had no risk factors. Excluding age and gender brought that figure to 62%.

Results were published online June 15 (Epub ahead of print).

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.